002030 达安基因
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额19,950780,1114,154,8523,304,5462,514,512
投资活动产生之现金流量净额(36,262)(63,691)(1,959,807)(1,379,283)(1,175,884)
筹资活动产生之现金流量净额(224,912)(2,323,269)(1,794,639)(626,548)(685,262)
汇率变动对现金及现金等价物的影响3732,25727,526(3,241)(9,933)
现金及现金等价物净增加/(减少)(240,851)(1,604,592)427,9321,295,473643,432
期初现金及现金等价物余额989,2742,593,8662,165,934870,460227,028
期末现金及现金等价物余额748,424989,2742,593,8662,165,934870,460